Ambale C, Chamwona S and Kataka J
Atazanavir is a protease inhibitor that is used as an antiretroviral drug. It is co-formulated with ritonavir to boost its plasma concentration and given together with two other antiretrovirals for a highly active regimen. As much as the drug literature warns of a cutaneous reaction, it has not communicated effectively on the possibility pf this occurring in patients with a sulphur allergy. No such case has been reported before. We report a case of a cutaneous adverse drug reaction in a male patient with a known allergy to sulphur in whom it was used for post-exposure prophylaxis. There is need for taking comprehensive patient history and relate it to reactions reported in literature to prevent recurrence of adverse reactions.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 